LIF is elevated in patient plasma in many different cancer types, and, therefore, it has potential as a non-specific cancer biomarker (although studies are needed to determine plasma levels of LIF in patients with non-cancer pathologies in addition to the healthy control subjects typically used). Here, LIF is linked to cancer.